Denali Therapeutics, Inc. (DNLI)
19.62
+0.21
(+1.08%)
USD |
NASDAQ |
Apr 08, 16:00
19.63
+0.01
(+0.05%)
After-Hours: 20:00
Denali Therapeutics Shareholders Equity (Quarterly) : 1.014B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 48.23M |
| Agenus, Inc. | -271.11M |
| Curis, Inc. | 5.462M |
| Plus Therapeutics, Inc. | 3.996M |
| Windtree Therapeutics, Inc. | -11.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.145B |
| Total Liabilities (Quarterly) | 131.09M |
| Debt to Equity Ratio | 0.0417 |
| Current Ratio | 9.158 |
| Net Debt Paydown Yield | 0.08% |